ProMIS Neurosciences Statistics
Share Statistics
ProMIS Neurosciences has 32.69M
shares outstanding. The number of shares has increased by 72.4%
in one year.
| Shares Outstanding | 32.69M |
| Shares Change (YoY) | 72.4% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 1,903 |
| FTD / Avg. Volume | 5.08% |
Short Selling Information
The latest short interest is 186.95K, so 0.57% of the outstanding
shares have been sold short.
| Short Interest | 186.95K |
| Short % of Shares Out | 0.57% |
| Short % of Float | 0.72% |
| Short Ratio (days to cover) | 4.46 |
Valuation Ratios
The PE ratio is 0.01 and the forward
PE ratio is -1.63.
ProMIS Neurosciences's PEG ratio is
0.
| PE Ratio | 0.01 |
| Forward PE | -1.63 |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 0 |
| P/FCF Ratio | -0.9 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
ProMIS Neurosciences has an Enterprise Value (EV) of -13.27B.
| EV / Sales | 0 |
| EV / EBITDA | 0.79 |
| EV / EBIT | 488.06 |
| EV / FCF | 488.06 |
Financial Position
The company has a current ratio of 8.52,
with a Debt / Equity ratio of 0.
| Current Ratio | 8.52 |
| Quick Ratio | 8.52 |
| Debt / Equity | 0 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 219.18 |
Financial Efficiency
Return on Equity is 16.85% and Return on Invested Capital is -100.81%.
| Return on Equity | 16.85% |
| Return on Assets | 14.69% |
| Return on Invested Capital | -100.81% |
| Revenue Per Employee | n/a |
| Profits Per Employee | $396,981,857.14 |
| Employee Count | 7 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -67.34% in the
last 52 weeks. The beta is 0.29, so ProMIS Neurosciences's
price volatility has been higher than the market average.
| Beta | 0.29 |
| 52-Week Price Change | -67.34% |
| 50-Day Moving Average | 0.68 |
| 200-Day Moving Average | 1.02 |
| Relative Strength Index (RSI) | 52.6 |
| Average Volume (20 Days) | 37,478 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -16.83B |
| Net Income | 2.78B |
| EBITDA | -16.83B |
| EBIT | 2.7B |
| Earnings Per Share (EPS) | 0.11 |
Full Income StatementBalance Sheet
The company has 13.29B in cash and 0 in
debt, giving a net cash position of 13.29B.
| Cash & Cash Equivalents | 13.29B |
| Total Debt | n/a |
| Net Cash | n/a |
| Retained Earnings | -90.69B |
| Total Assets | 18.91M |
| Working Capital | 16.69M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -27.18M
and capital expenditures 0, giving a free cash flow of -27.18M.
| Operating Cash Flow | -27.18M |
| Capital Expenditures | n/a |
| Free Cash Flow | -27.18M |
| FCF Per Share | -1.05 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
